Alerts will be sent to your verified email
Verify EmailVAISHALI
Vaishali Pharma
|
BDH Inds
|
Quest Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
7.61 % | 14.8 % | 30.21 % |
5yr average Equity Multiplier
|
2.76 | 1.46 | 2.94 |
5yr Average Asset Turnover Ratio
|
0.89 | 0.89 | 1.51 |
5yr Avg Net Profit Margin
|
3.52 % | 11.59 % | 7.37 % |
Price to Book
|
2.45 | 2.31 | 0.0 |
P/E
|
398.6 | 16.68 | 11.97 |
5yr Avg Cash Conversion Cycle
|
133.52 Days | -27.79 Days | 1.67 Days |
Inventory Days
|
6.09 Days | 31.79 Days | 28.09 Days |
Days Receivable
|
217.95 Days | 116.74 Days | 95.81 Days |
Days Payable
|
174.07 Days | 156.43 Days | 139.44 Days |
5yr Average Interest Coverage Ratio
|
2.44 | 78.47 | 14.47 |
5yr Avg ROCE
|
16.76 % | 19.81 % | 39.56 % |
5yr Avg Operating Profit Margin
|
6.18 % | 14.91 % | 11.77 % |
5 yr average Debt to Equity
|
0.6 | 0.1 | 0.32 |
5yr CAGR Net Profit
|
88.82 % | 7.83 % | 72.53 % |
5yr Average Return on Assets
|
3.1 % | 10.19 % | 10.78 % |
Shareholdings
|
|||
Promoter Holding
|
26.32 % | 49.7 % | 66.21 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.42 % | 0.04 % | 0.38 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Vaishali Pharma
|
BDH Inds
|
Quest Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|